nimodipine has been researched along with Osteogenic Sarcoma in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Econazole is an antifungal drug with different in vitro effects." | 5.33 | Econazole induces increases in free intracellular Ca2+ concentrations in human osteosarcoma cells. ( Chang, CH; Chang, HT; Chen, JS; Chen, WC; Chou, CT; Hsieh, CH; Hsu, SS; Huang, JK; Jan, CR; Jiann, BP; Liu, CS; Liu, SI, 2005) |
| "Econazole is an antifungal drug with different in vitro effects." | 1.33 | Econazole induces increases in free intracellular Ca2+ concentrations in human osteosarcoma cells. ( Chang, CH; Chang, HT; Chen, JS; Chen, WC; Chou, CT; Hsieh, CH; Hsu, SS; Huang, JK; Jan, CR; Jiann, BP; Liu, CS; Liu, SI, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HT | 1 |
| Liu, CS | 1 |
| Chou, CT | 1 |
| Hsieh, CH | 1 |
| Chang, CH | 1 |
| Chen, WC | 1 |
| Liu, SI | 1 |
| Hsu, SS | 1 |
| Chen, JS | 1 |
| Jiann, BP | 1 |
| Huang, JK | 1 |
| Jan, CR | 1 |
1 other study available for nimodipine and Osteogenic Sarcoma
| Article | Year |
|---|---|
Econazole induces increases in free intracellular Ca2+ concentrations in human osteosarcoma cells.
Topics: Antifungal Agents; Bone Neoplasms; Calcium; Calcium Channel Blockers; Calcium Signaling; Cell Line, | 2005 |